So, 3 or 4 months not unexpected, demonstrating precedent. Many thanks for looking LED.
The tone of today's ann seems to be at pains to suggest this may be the case for MSB too (listing prior successful prod facility inspection etc.). We shall see. As I won't be selling any until decision due to terminal laziness, I don't have timing risk or fomo.
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-198
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
-0.075(5.12%) |
Mkt cap ! $1.587B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.46 | $1.37 | $9.337M | 6.672M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 80200 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 28642 | 2 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |